Tau-Neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum
Lyu, X.; Duong, M. T.; Xie, L.; de Flores, R.; Richardson, H.; Hwang, G.; Wisse, L. E. M.; DiCalogero, M.; McMillan, C. T.; Robinson, J. L.; Xie, S. X.; Grossman, M.; Lee, E. B.; Irwin, D. J.; Dickerson, B. C.; Davatzikos, C.; Nasrallah, I. M.; Yushkevich, P.; Wolk, D. A.; Das, S. R.
Show abstract
Variability in the relationship of tau-based neurofibrillary tangles (T) and degree of neurodegeneration (N) in Alzheimers Disease (AD) is likely attributable to the non-specific nature of N, which is also modulated by such factors as other co-pathologies, age-related changes, and developmental differences. We studied this variability by partitioning patients within the Alzheimers continuum into data-driven groups based on their regional T-N dissociation, which reflects the residuals after the effect of tau pathology is "removed". We found six groups displaying distinct spatial T-N mismatch and thickness patterns despite similar tau burden. Their T-N patterns resembled the neurodegeneration patterns of non-AD groups partitioned on the basis of z-scores of cortical thickness alone and were similarly associated with surrogates of non-AD factors. In an additional sample of individuals with antemortem imaging and autopsy, T-N mismatch was associated with TDP-43 co-pathology. Finally, T-N mismatch training was then applied to a separate cohort to determine the ability to classify individual patients within these groups. These findings suggest that T-N mismatch may provide a personalized approach for determining non-AD factors associated with resilience/vulnerability to Alzheimers disease.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease 98%
- Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease 98%
- Head-to-head comparison between plasma p-tau217 and Flortaucipir-PET in amyloid-positive patients with cognitive impairment 97%
Similar papers in this journal
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 99%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 98%
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease 98%
Similar papers in this journal
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 98%
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 98%
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 97%